Health Status and the Spiral of Decline

REFERENCES

• Jones P W. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56(11)880–887
   PubMed Web of Science ®Google Scholar
• Jones P W, Quirk F H, Baveystock C M, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145(6)1321–1327
   PubMed Web of Science ®Google Scholar
• Guyatt G H, Berman L B, Townsend M, Pugsley S O, Chambers L W. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42(10)773–778
   PubMed Web of Science ®Google Scholar
• Hyland M E, Bott J, Singh S, Kenyon C A. Domains, constructs and the development of the breathing problems questionnaire. Qual Life Res 1994; 3(4)245–256
   PubMed Web of Science ®Google Scholar
• Hyland M E, Singh S J, Sodergren S C, Morgan M P. Development of a shortened version of the Breathing Problems Questionnaire suitable for use in a pulmonary rehabilitation clinic: a purpose-specific, disease-specific questionnaire. Qual Life Res 1998; 7(3)227–233
   PubMed Web of Science ®Google Scholar
• Maille A R, Koning C J, Zwinderman A H, Willems L N, Dijkman J H, Kaptein A A. The development of the ‘Quality-of-life for Respiratory Illness Questionnaire (QOL-RIQ)’: a disease-specific quality-of-life questionnaire for patients with mild to moderate chronic non-specific lung disease. Respir Med 1997; 91(5)297–309
   PubMed Web of Science ®Google Scholar
• Spencer S, Calverley P M, Sherwood Burge P, Jones P W. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163(1)122–128
   PubMed Web of Science ®Google Scholar
• Jones P W, Bosh T K. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997; 155(4)1283–1289
   PubMed Web of Science ®Google Scholar
• Spencer S, Calverley P M, Burge P S, Jones P W. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004; 23(5)698–702
   PubMed Web of Science ®Google Scholar
• Carone M, Bertolotti G, Anchisi F, Zotti A M, Donner C F, Jones P W. Analysis of factors that characterize health impairment in patients with chronic respiratory failure. Quality of Life in Chronic Respiratory Failure Group. Eur Respir J 1999; 13(6)1293–1300
   PubMed Web of Science ®Google Scholar
• Engstrom C P, Persson L O, Larsson S, Ryden A, Sullivan M. Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study. Thorax 1996; 51(8)825–830
   PubMed Web of Science ®Google Scholar
• Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 785–790, (3 Pt 1)
   PubMed Web of Science ®Google Scholar
• Carone M. SGRQ score and mortality in COPD patients with severe hypoxia (QUESS study). La Valutazione Dell Outcome In Riabilitazione Respiratoria. PerugiaItaly 2006
   Google Scholar
• Carone M, Ambrosino N, Bertolotti G, et al. Quality of Life Evaluation and Survival Study: a 3-yr prospective multinational study on patients with chronic respiratory failure. Monaldi Arch Chest Dis 2001; 56(1)17–22
   PubMedGoogle Scholar
• Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166(5)680–685
   PubMed Web of Science ®Google Scholar
• Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167(4)544–549
   PubMed Web of Science ®Google Scholar
• Jones P W, Agusti A G. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 2006; 27(4)822–832
   PubMed Web of Science ®Google Scholar
• Jones P, Spencer S, Duprat-Lomon I, Sagnier P.-P. Short-term recovery in SGRQ from an acute exacerbation in the MOSAIC study correlates with the preceding deterioration, but is larger. Eur Respir J 2004; 24: 686s
   Google Scholar
• Calverley P M, Spencer S, Willits L, Burge P S, Jones P W. Withdrawal from treatment as an outcome in the ISOLDE study of COPD. Chest 2003; 124(4)1350–1356
   PubMed Web of Science ®Google Scholar
• Donaldson G C, Wilkinson T M, Hurst J R, Perera W R, Wedzicha J A. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171(5)446–452
   PubMed Web of Science ®Google Scholar
• Vincken W, van Noord J A, Greefhorst A P, et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 2002; 19(2)209–216
   PubMed Web of Science ®Google Scholar
• Casaburi R, Mahler D A, Jones P W, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19(2)217–224
   PubMed Web of Science ®Google Scholar
• Niewoehner D, Rice K, Cote C, Paulson D, Cooper J, Korducki L. Reduced COPD exacerbation and associated health care utilization with once-daily tiotropium in the VA medical system. Am J Respir Crit Care Med 2004; 169: A207
   Google Scholar
• Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 2003; 58(5)399–404
   PubMed Web of Science ®Google Scholar
• Niewoehner D E, Rice K, Cote C, et al. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med 2005; 143(5)317–326
   PubMed Web of Science ®Google Scholar
• Calverley P M, Anderson J A, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356(8)775–789
   PubMed Web of Science ®Google Scholar